401 related articles for article (PubMed ID: 15808506)
1. Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization.
Saridakis V; Sheng Y; Sarkari F; Holowaty MN; Shire K; Nguyen T; Zhang RG; Liao J; Lee W; Edwards AM; Arrowsmith CH; Frappier L
Mol Cell; 2005 Apr; 18(1):25-36. PubMed ID: 15808506
[TBL] [Abstract][Full Text] [Related]
2. Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP.
Holowaty MN; Sheng Y; Nguyen T; Arrowsmith C; Frappier L
J Biol Chem; 2003 Nov; 278(48):47753-61. PubMed ID: 14506283
[TBL] [Abstract][Full Text] [Related]
3. Molecular recognition of p53 and MDM2 by USP7/HAUSP.
Sheng Y; Saridakis V; Sarkari F; Duan S; Wu T; Arrowsmith CH; Frappier L
Nat Struct Mol Biol; 2006 Mar; 13(3):285-91. PubMed ID: 16474402
[TBL] [Abstract][Full Text] [Related]
4. HAUSP/USP7 as an Epstein-Barr virus target.
Holowaty MN; Frappier L
Biochem Soc Trans; 2004 Nov; 32(Pt 5):731-2. PubMed ID: 15494000
[TBL] [Abstract][Full Text] [Related]
5. Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7.
Holowaty MN; Zeghouf M; Wu H; Tellam J; Athanasopoulos V; Greenblatt J; Frappier L
J Biol Chem; 2003 Aug; 278(32):29987-94. PubMed ID: 12783858
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
Sivachandran N; Sarkari F; Frappier L
PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway.
Hu M; Gu L; Li M; Jeffrey PD; Gu W; Shi Y
PLoS Biol; 2006 Feb; 4(2):e27. PubMed ID: 16402859
[TBL] [Abstract][Full Text] [Related]
8. EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication.
Sarkari F; Sanchez-Alcaraz T; Wang S; Holowaty MN; Sheng Y; Frappier L
PLoS Pathog; 2009 Oct; 5(10):e1000624. PubMed ID: 19834552
[TBL] [Abstract][Full Text] [Related]
9. C-terminal region of USP7/HAUSP is critical for deubiquitination activity and contains a second mdm2/p53 binding site.
Ma J; Martin JD; Xue Y; Lor LA; Kennedy-Wilson KM; Sinnamon RH; Ho TF; Zhang G; Schwartz B; Tummino PJ; Lai Z
Arch Biochem Biophys; 2010 Nov; 503(2):207-12. PubMed ID: 20816748
[TBL] [Abstract][Full Text] [Related]
10. A New Insight Into p53-Inhibiting Genes in Epstein–Barr Virus-Associated Gastric Adenocarcinoma.
Hashemi SMA; Moradi A; Hosseini SY; Razavi Nikoo H; Bamdad T; Faghih Z; Sarvari J; Tabarraei A
Iran Biomed J; 2023 Jan; 27(1):34-45. PubMed ID: 36624687
[TBL] [Abstract][Full Text] [Related]
11. Identification of Kaposi Sarcoma Herpesvirus (KSHV) vIRF1 Protein as a Novel Interaction Partner of Human Deubiquitinase USP7.
Chavoshi S; Egorova O; Lacdao IK; Farhadi S; Sheng Y; Saridakis V
J Biol Chem; 2016 Mar; 291(12):6281-91. PubMed ID: 26786098
[TBL] [Abstract][Full Text] [Related]
12. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
Frappier L
Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
[TBL] [Abstract][Full Text] [Related]
13. Interaction between basic residues of Epstein-Barr virus EBNA1 protein and cellular chromatin mediates viral plasmid maintenance.
Kanda T; Horikoshi N; Murata T; Kawashima D; Sugimoto A; Narita Y; Kurumizaka H; Tsurumi T
J Biol Chem; 2013 Aug; 288(33):24189-99. PubMed ID: 23836915
[TBL] [Abstract][Full Text] [Related]
14. The 2.2 A structure of a permanganate-sensitive DNA site bound by the Epstein-Barr virus origin binding protein, EBNA1.
Bochkarev A; Bochkareva E; Frappier L; Edwards AM
J Mol Biol; 1998 Dec; 284(5):1273-8. PubMed ID: 9878348
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, EBNA1, bound to DNA.
Bochkarev A; Barwell JA; Pfuetzner RA; Bochkareva E; Frappier L; Edwards AM
Cell; 1996 Mar; 84(5):791-800. PubMed ID: 8625416
[TBL] [Abstract][Full Text] [Related]
16. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
Deakyne JS; Malecka KA; Messick TE; Lieberman PM
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406
[TBL] [Abstract][Full Text] [Related]
17. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
[TBL] [Abstract][Full Text] [Related]
18. Expression of Epstein-Barr virus EBNA1 protein in Escherichia coli: purification under nondenaturing conditions and use in DNA-binding studies.
Bouallag N; Gaillard C; Maréchal V; Strauss F
Protein Expr Purif; 2009 Sep; 67(1):35-40. PubMed ID: 19393319
[TBL] [Abstract][Full Text] [Related]
19. Optimal transactivation by Epstein-Barr nuclear antigen 1 requires the UR1 and ATH1 domains.
Singh G; Aras S; Zea AH; Koochekpour S; Aiyar A
J Virol; 2009 May; 83(9):4227-35. PubMed ID: 19244333
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies.
Sivachandran N; Cao JY; Frappier L
J Virol; 2010 Nov; 84(21):11113-23. PubMed ID: 20719947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
